Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210470
Status:
COMPLETED
Last Update Posted:
2020-12-11
First Post:
2005-09-13
Brief Title:
A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
Sponsor:
Brooklyn ImmunoTherapeutics LLC
Organization:
Brooklyn ImmunoTherapeutics LLC